한글목차

재택 헬스케어 시장 규모는 2025년 4,088억 5,000만 달러에서 2026년부터 2034년까지 CAGR 7.4%로 성장하여 2034년에는 7,773억 2,000만 달러에 달할 것으로 예측됩니다.

재택 헬스케어 시장은 고령화 사회의 진전과 집에서 편안한 환경에서 돌봄을 받고자 하는 수요 증가를 배경으로 큰 변화를 맞이하고 있습니다. 만성질환을 앓고 있는 환자들의 요구를 충족시키기 위해 의료시스템이 진화하면서 재택의료 서비스 및 제품에 대한 수요가 급증하고 있습니다. 이러한 추세는 원격의료 기술의 발전으로 더욱 가속화되고 있습니다. 원격의료 기술을 통해 의료 제공자는 원격으로 모니터링 및 진찰을 제공할 수 있게 되어 환자의 의료 접근성이 향상되고 있습니다.

의료기기 및 홈 헬스케어 기술 혁신도 이 시장의 미래를 형성하는 데 매우 중요한 역할을 하고 있습니다. 웨어러블 기기, 모바일 헬스 애플리케이션, 스마트홈 기술은 환자가 자신의 건강관리를 주도적으로 할 수 있도록 지원하며, 바이탈 사인과 건강 지표를 실시간으로 모니터링할 수 있게 해줍니다. 이러한 발전은 환자의 참여를 촉진할 뿐만 아니라 의료 전문가가 적시에 개입할 수 있게 하여 궁극적으로 더 나은 건강 결과로 이어질 수 있습니다.

또한, 맞춤형 케어에 대한 관심이 높아지면서 환자 개개인의 고유한 니즈를 충족시키기 위해 재택 헬스케어 솔루션의 맞춤화가 진행되고 있습니다. 이러한 추세는 의료 제공자, 기술 개발자, 환자 간의 협업을 촉진하고 환자 경험 전반을 향상시키는 맞춤형 케어 플랜의 실현으로 이어지고 있습니다. 또한, 가치 기반 의료 모델의 부상으로 의료 기관은 재택 의료 서비스에 대한 투자를 촉진하고 있습니다. 이는 비용 절감과 환자 만족도를 높일 수 있는 가능성을 인식한 결과입니다. 요약하면, 재택 헬스케어 시장은 혁신, 환자 중심의 솔루션, 그리고 재택 치료를 받는 개인의 삶의 질을 향상시키기 위한 노력으로 특징지어지는 등 괄목할 만한 성장세를 보이고 있습니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 재택 헬스케어 시장 : 제품별

제5장 세계의 재택 헬스케어 시장 : 서비스별

제6장 세계의 재택 헬스케어 시장 : 적응증별

제7장 세계의 재택 헬스케어 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The Home Healthcare Market size is expected to reach USD 777.32 Billion in 2034 from USD 408.85 Billion (2025) growing at a CAGR of 7.4% during 2026-2034.

The home healthcare market is witnessing a remarkable transformation, driven by an aging population and a growing preference for receiving care in the comfort of one's home. As healthcare systems evolve to accommodate the needs of patients with chronic conditions, the demand for home healthcare services and products is surging. This trend is further fueled by advancements in telehealth technologies, which enable healthcare providers to deliver remote monitoring and consultations, thereby enhancing patient access to care.

Innovations in medical devices and home health technologies are also playing a pivotal role in shaping the future of this market. Wearable devices, mobile health applications, and smart home technologies are empowering patients to take charge of their health, facilitating real-time monitoring of vital signs and health metrics. These advancements not only improve patient engagement but also enable healthcare professionals to make timely interventions, ultimately leading to better health outcomes.

Furthermore, the increasing focus on personalized care is driving the customization of home healthcare solutions to meet the unique needs of individual patients. This trend is fostering collaboration between healthcare providers, technology developers, and patients, resulting in tailored care plans that enhance the overall patient experience. Additionally, the rise of value-based care models is encouraging healthcare organizations to invest in home healthcare services, recognizing the potential for cost savings and improved patient satisfaction. In summary, the home healthcare market is poised for significant growth, characterized by innovation, patient-centric solutions, and a commitment to enhancing the quality of life for individuals receiving care at home.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Therapeutic Products
• Testing, Screening, and Monitoring Products
• Mobility Care Products

By Service

• Skilled Nursing
• Rehabilitation Therapy
• Hospice & Palliative Care
• Unskilled Care
• Respiratory Therapy
• Infusion Therapy
• Pregnancy Care

By Indication

• Cancer
• Respiratory Diseases
• Movement Disorders
• Cardiovascular Diseases & Hypertension
• Pregnancy
• Wound Care
• Diabetes
• Hearing Disorders
• Other

COMPANIES PROFILED

• Fresenius SE Co KGaA, Abbott, GE Healthcare, Koninklijke Philips NV, ResMed Inc, Linde Plc, F HoffmannLa Roche Ltd, B Braun Melsungen AG, 3M Healthcare, Baxter International Inc, Medtronic Plc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HOME HEALTHCARE MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Therapeutic Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Testing, Screening, and Monitoring Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Mobility Care Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HOME HEALTHCARE MARKET: BY SERVICE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Service
• 5.2. Skilled Nursing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rehabilitation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hospice & Palliative Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Unskilled Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Respiratory Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Infusion Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Pregnancy Care Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HOME HEALTHCARE MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Movement Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiovascular Diseases & Hypertension Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Pregnancy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Wound Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Hearing Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.10. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HOME HEALTHCARE MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Service
  • 7.2.3 By Indication
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Service
  • 7.3.3 By Indication
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Service
  • 7.4.3 By Indication
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Service
  • 7.5.3 By Indication
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Service
  • 7.6.3 By Indication
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HOME HEALTHCARE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Fresenius SE & Co. KGaA
  • 9.2.2 Abbott
  • 9.2.3 GE Healthcare
  • 9.2.4 Koninklijke Philips NV
  • 9.2.5 ResMed Inc
  • 9.2.6 Linde Plc
  • 9.2.7 F. Hoffmann-La Roche Ltd
  • 9.2.8 B. Braun Melsungen AG
  • 9.2.9 3M Healthcare
  • 9.2.10 Baxter International Inc
  • 9.2.11 Medtronic Plc